By Bhanvi Satija and Sabrina Valle LONDON, June 11 (Reuters) – GSK's record $10.6 billion deal for U.S. company Nuvalent will accelerate the British drugmaker's rebuild of its cancer drug business as
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
'Super desperate' Sabalenka thrilled with win over Pegula in US Open semis
VIDEO SHOWS: US OPEN SEMI-FINALS POST MATCH PRESS CONFERENCE SOUNDBITES FROM ARYNA SABALENKA AND JESSICA…
UPDATE 1-Tennis-Rybakina beats Gauff to book US Open final against Sabalenka
(Adds quotes, details) By Shrivathsa Sridhar NEW YORK, Sept 10 (Reuters) - Elena Rybakina overpowered…
More US lawmakers call for new AI rules after Anthropic researchers warn of human extinction
By Courtney Rozen Sept 10 (Reuters) - Growing numbers of U.S. lawmakers are calling for…
